Jazz Pharmaceuticals
JAZZ
JAZZ
373 hedge funds and large institutions have $9.87B invested in Jazz Pharmaceuticals in 2015 Q2 according to their latest regulatory filings, with 51 funds opening new positions, 121 increasing their positions, 146 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
28% less funds holding in top 10
Funds holding in top 10: 18 → 13 (-5)
52% less call options, than puts
Call options by funds: $54M | Put options by funds: $113M
Holders
373
Holding in Top 10
13
Calls
$54M
Puts
$113M
Top Buyers
| 1 | +$267M | |
| 2 | +$255M | |
| 3 | +$75.1M | |
| 4 |
BG
BlackRock Group
London,
United Kingdom
|
+$69.7M |
| 5 |
NC
Nicholas Company
Milwaukee,
Wisconsin
|
+$59.2M |
Top Sellers
| 1 | -$66.8M | |
| 2 | -$64.2M | |
| 3 | -$56.2M | |
| 4 |
LPC
Lone Pine Capital
Greenwich,
Connecticut
|
-$45.1M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$26.7M |